Related Experiment Video

Updated: Jul 27, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

VasoCare. Vasogen

F Visioli1

  • 1University of Milan, Department of Pharmacological Sciences, Via Balzaretti 9, 20133, Milan, Italy. francesco.visioli@unimi.it

Current Opinion in Investigational Drugs (London, England : 2000)
|November 23, 2001
PubMed

Insights

Vasogen is developing VasoCare, an immune modulation therapy, for peripheral vascular disease and atherosclerosis. Clinical trials are progressing, and a patent has been issued for its use in preventing and reversing atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Pharmacology

Background:

  • Peripheral vascular disease (PVD) and atherosclerosis are significant cardiovascular conditions.
  • Current treatments for PVD and atherosclerosis have limitations.
  • Immune modulation therapies offer a novel approach to cardiovascular disease treatment.

Purpose of the Study:

  • To evaluate VasoCare, an immune modulation therapy, as a potential treatment for PVD and atherosclerosis.
  • To assess the safety and efficacy of VasoCare in clinical trials.
  • To support regulatory approval for VasoCare.

Main Methods:

  • VasoCare is an immune modulation therapy under development by Vasogen.
  • Late phase II trials for PVD were conducted in the UK.
  • Phase I/II trials were initiated in the US, Canada, and Europe.
  • A US multicenter trial for PVD was planned.
  • A patent was granted for the use of VasoCare in preventing and reversing atherosclerosis.

Main Results:

  • VasoCare has undergone late phase II and phase I/II clinical trials for PVD.
  • Regulatory approval support trials were planned.
  • A patent was issued for VasoCare's application in atherosclerosis prevention and reversal.

Conclusions:

  • VasoCare shows potential as an immune modulation therapy for PVD and atherosclerosis.
  • Ongoing clinical development and patent protection indicate promising therapeutic prospects.
  • Further clinical trials are necessary to confirm efficacy and safety for regulatory approval.

More Related Videos

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models06:16

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Published on: March 16, 2022

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...